March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • Mohd I. Nawaz
    Ophthalmology, Kind Saud University, Riyadh, Saudi Arabia
  • Mohammad S. Ola
    Ophthalmology, Kind Saud University, Riyadh, Saudi Arabia
  • Mohammed M. Siddiquei
    Ophthalmology, Kind Saud University, Riyadh, Saudi Arabia
  • Karel Geboes
    Laboratory of Histochemistry and Cytochemistry, University of Leuven, Leuven, Belgium
  • Ahmed A. El-Asrar
    Ophthalmology, Kind Saud University, Riyadh, Saudi Arabia
  • Footnotes
    Commercial Relationships  Mohd I. Nawaz, None; Mohammad S. Ola, None; Mohammed M. Siddiquei, None; Karel Geboes, None; Ahmed A. El-Asrar, None
  • Footnotes
    Support  Dr.Nasir Al-Rasheed Research Chair in Ophthalmology and JDRF
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5756. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mohd I. Nawaz, Mohammad S. Ola, Mohammed M. Siddiquei, Karel Geboes, Ahmed A. El-Asrar; Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5756.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine levels of angiogenic and endothelial progenitor cell mobilizing (vasculogenic) factors in vitreous fluid from proliferative diabetic retinopathy (PDR) patients and correlate their levels with clinical disease activity.

Methods: : Vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor-2 (sVEGFR-2), stem cell factor (SCF), soluble c-kit (s-kit) and prostaglandin E2 (PGE2) levels were measured by ELISA in vitreous samples from 34 PDR and 15 nondiabetic patients.

Results: : VEGF, sVEGFR-2, SCF, and s-kit levels and mean VEGF to sVEGFR-2 ratio were significantly higher in PDR with active neovascularization compared with quiescent PDR and nondiabetic patients (p<0.001; 0.007; 0.001; <0.001; 0.0103, respectively). VEGF, sVEGFR-2, SCF and s-kit levels and mean VEGF to sVEGFR-2 ratio were significantly higher in PDR with hemorrhage compared with PDR without hemorrhage and nondiabetic patients (p<0.001; 0.003; 0.001; 0.001; 0.0181, respectively). PGE2 levels were significantly higher in nondiabetic patients compared with PDR patients (p<0.001). There were significant correlations between levels of sVEGFR-2 versus SCF (r=0.950, p<0.001), sVEGFR-2 versus s-kit (r=0.941, p<0.001) and SCF versus s-kit (r=0.970, p<0.001).

Conclusions: : Upregulation of VEGF, sVEGFR-2, SCF and s-kit supports the contributions of angiogenesis and vasculogenesis in pathogenesis of PDR.

Keywords: diabetic retinopathy • vitreous • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×